Share:
Peer-Reviewed Publication
JMIR Mhealth Uhealth2025;13e64846.September 24, 2025Journal Article

Impact of a 24-Week Mobile App-Based Human Coaching Program on Body Composition and Lipid Metabolism in Breast Cancer Survivors With Overweight or Obesity: Single-Arm Prospective Cohort Study.

Eun-Gyeong Lee1,2, Dong-Eun Lee3, Jeongseon Kim1, Jaihong Han2, Seeyoun Lee2, Han-Sung Kang2, Eun Sook Lee2, Heejung Chae2, Sung Hoon Sim2, Keun Seok Lee2, Jungeun Lee4, Hyun Jeong Lee5, Ji Sung Yoo6, Gyung Ah Wie7, So-Youn Jung1,2
1Department of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Republic of Korea.
2Center for Breast Cancer, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang, 10408, Republic of Korea, 82 31-920-1681, 82 31-920-2799.
3Biostatistics Collaboration Team, Research Core Center, Research Institute of National Cancer Center, Goyang, Republic of Korea.
4Noom, Inc., New York, NY, United States.
5Department of Psychiatry and Behavioral Science, National Cancer Center, Goyang, Republic of Korea.
6Department of Rehabilitation Medicine, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea.
7Department of Clinical Nutrition, National Cancer Center, Goyang, Republic of Korea.

Abstract

BACKGROUND: Overweight or obesity is a prognostic factor for breast cancer recurrence and breast cancer-related deaths. However, weight control is difficult for breast cancer survivors because of menopause, chemotherapy, antihormonal therapy, and psychological issues. OBJECTIVE: This study aimed to develop a 24-week mobile app-based human coaching program using Noom and evaluate its efficacy in b…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.